Literature DB >> 27383348

[Not Available].

Mariana Soares Valença1, Lia Gonçalves Possuelo2, Marta Regina Cezar-Vaz3, Pedro Eduardo Almeida da Silva4.   

Abstract

The scope of this study was to organize the knowledge produced on tuberculosis in Brazilian prisons in a systematic manner. A comprehensive review was conducted in the Medline and Lilacs databases and the SciELO electronic library using the key words: "Tuberculosis," "Prisons" and "Brazil." Of the 61 records found, 33 were evaluated (28 duplicated records) and 21 included in the review (12 excluded according to the criteria adopted). These studies contribute effectively to improve the knowledge regarding the scale of the disease among inmates, as well as to the choice of screening and diagnostic methods most appropriate to the prison setting. The incidence rates and prevalence of active and latent tuberculosis are presented, in addition to data on the profile of drug and genotype susceptibility of the clinical results. Awareness of the data presented highlights the need to adopt measures aimed at case detection, treatment and follow-up. It is suggested that the new challenges for scientific research should be linked to the development of specific knowledge about dealing with the problem in an environment full of specificities such as a prison.

Entities:  

Mesh:

Year:  2016        PMID: 27383348     DOI: 10.1590/1413-81232015217.16172015

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  Cardiovascular Risk in Women Deprived of Freedom from a Public Prison in Mato Grosso, Brazil.

Authors:  Nicolly Beatriz Hachbardt; Thalise Yuri Hattori; Vagner Ferreira do Nascimento; Juliana Herrero da Silva; Ana Cláudia Pereira Terças-Trettel; Viviane Karolina Vivi Oliveira; Marina Atanaka
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-07

2.  Tuberculosis and latent infection in employees of different prison unit types.

Authors:  Péricles Alves Nogueira; Regina Maura Cabral de Melo Abrahão; Vera Maria Neder Galesi; Rossana Verónica Mendoza López
Journal:  Rev Saude Publica       Date:  2018-02-05       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.